Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1250389

Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease


Virović Jukić, Lucija; Grgurević, Ivica; Mikolašević, Ivana; Filipec Kanižaj, Tajana; Milić, Sandra; Mrzljak, Anna; Premužić, Marina; Hrstić, Irena; Knežević Štromar, Ivana; Ljubičić, Neven et al.
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease // Acta clinica Croatica, 60 (2021), Suppl 2; 36-52 doi:10.20471/acc.2021.60.s1.03 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1250389 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease

Autori
Virović Jukić, Lucija ; Grgurević, Ivica ; Mikolašević, Ivana ; Filipec Kanižaj, Tajana ; Milić, Sandra ; Mrzljak, Anna ; Premužić, Marina ; Hrstić, Irena ; Knežević Štromar, Ivana ; Ljubičić, Neven ; Ostojić, Rajko ; Stojsavljević Shapeski, Sanja ; Amerl-Šakić, Vjekoslava ; Bašić Marković, Nina ; Rađa, Marko ; Soldo, Dragan ; Sobočan, Nikola ; Lalovac, Miloš ; Puljiz, Željko ; Podrug, Kristian ; Ladić, Dinko

Izvornik
Acta clinica Croatica (0353-9466) 60 (2021), Suppl 2; 36-52

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
nonalcoholic fatty liver disease (NAFLD) ; nonalcoholic steatohepatitis (NASH) ; metabolic syndrome ; screening ; noninvasive methods ; hepatocellular carcinoma

Sažetak
Nonalcoholic fatty liver disease (NAFLD) is a term describing excessive accumulation of fat in hepatocytes, and is associated with metabolic syndrome and insulin resistance. NAFLD prevalence is on increase and goes in parallel with the increasing prevalence of metabolic syndrome and its components. That is why Croatian guidelines have been developed, which cover the screening protocol for patients with NAFLD risk factors, and the recommended diagnostic work-up and treatment of NAFLD patients. NAFLD screening should be done in patients with type 2 diabetes mellitus, or persons with two or more risk factors as part of metabolic screening, and is carried out by noninvasive laboratory and imaging methods used to detect fibrosis. Patient work-up should exclude the existence of other causes of liver injury and determine the stage of fibrosis as the most important factor in disease prognosis. Patients with initial stages of fibrosis continue to be monitored at the primary healthcare level with the management of metabolic risk factors, dietary measures, and increased physical activity. Patients with advanced fibrosis should be referred to a gastroenterologist/ hepatologist for further treatment, monitoring, and detection and management of complications

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Merkur",
Medicinski fakultet, Rijeka,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
KBC "Sestre Milosrdnice",
KBC Split,
Opća bolnica Pula,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb,
Medicinski fakultet, Split,
Klinički bolnički centar Rijeka

Poveznice na cjeloviti tekst rada:

doi hrcak.srce.hr

Citiraj ovu publikaciju:

Virović Jukić, Lucija; Grgurević, Ivica; Mikolašević, Ivana; Filipec Kanižaj, Tajana; Milić, Sandra; Mrzljak, Anna; Premužić, Marina; Hrstić, Irena; Knežević Štromar, Ivana; Ljubičić, Neven et al.
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease // Acta clinica Croatica, 60 (2021), Suppl 2; 36-52 doi:10.20471/acc.2021.60.s1.03 (međunarodna recenzija, pregledni rad, znanstveni)
Virović Jukić, L., Grgurević, I., Mikolašević, I., Filipec Kanižaj, T., Milić, S., Mrzljak, A., Premužić, M., Hrstić, I., Knežević Štromar, I. & Ljubičić, N. (2021) Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. Acta clinica Croatica, 60 (Suppl 2), 36-52 doi:10.20471/acc.2021.60.s1.03.
@article{article, author = {Virovi\'{c} Juki\'{c}, Lucija and Grgurevi\'{c}, Ivica and Mikola\v{s}evi\'{c}, Ivana and Filipec Kani\v{z}aj, Tajana and Mili\'{c}, Sandra and Mrzljak, Anna and Premu\v{z}i\'{c}, Marina and Hrsti\'{c}, Irena and Kne\v{z}evi\'{c} \v{S}tromar, Ivana and Ljubi\v{c}i\'{c}, Neven and Ostoji\'{c}, Rajko and Stojsavljevi\'{c} Shapeski, Sanja and Amerl-\v{S}aki\'{c}, Vjekoslava and Ba\v{s}i\'{c} Markovi\'{c}, Nina and Ra\dja, Marko and Soldo, Dragan and Sobo\v{c}an, Nikola and Lalovac, Milo\v{s} and Puljiz, \v{Z}eljko and Podrug, Kristian and Ladi\'{c}, Dinko}, year = {2021}, pages = {36-52}, DOI = {10.20471/acc.2021.60.s1.03}, keywords = {nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic syndrome, screening, noninvasive methods, hepatocellular carcinoma}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2021.60.s1.03}, volume = {60}, number = {Suppl 2}, issn = {0353-9466}, title = {Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease}, keyword = {nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic syndrome, screening, noninvasive methods, hepatocellular carcinoma} }
@article{article, author = {Virovi\'{c} Juki\'{c}, Lucija and Grgurevi\'{c}, Ivica and Mikola\v{s}evi\'{c}, Ivana and Filipec Kani\v{z}aj, Tajana and Mili\'{c}, Sandra and Mrzljak, Anna and Premu\v{z}i\'{c}, Marina and Hrsti\'{c}, Irena and Kne\v{z}evi\'{c} \v{S}tromar, Ivana and Ljubi\v{c}i\'{c}, Neven and Ostoji\'{c}, Rajko and Stojsavljevi\'{c} Shapeski, Sanja and Amerl-\v{S}aki\'{c}, Vjekoslava and Ba\v{s}i\'{c} Markovi\'{c}, Nina and Ra\dja, Marko and Soldo, Dragan and Sobo\v{c}an, Nikola and Lalovac, Milo\v{s} and Puljiz, \v{Z}eljko and Podrug, Kristian and Ladi\'{c}, Dinko}, year = {2021}, pages = {36-52}, DOI = {10.20471/acc.2021.60.s1.03}, keywords = {nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic syndrome, screening, noninvasive methods, hepatocellular carcinoma}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2021.60.s1.03}, volume = {60}, number = {Suppl 2}, issn = {0353-9466}, title = {Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease}, keyword = {nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic syndrome, screening, noninvasive methods, hepatocellular carcinoma} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font